JPS505523A - - Google Patents

Info

Publication number
JPS505523A
JPS505523A JP48054145A JP5414573A JPS505523A JP S505523 A JPS505523 A JP S505523A JP 48054145 A JP48054145 A JP 48054145A JP 5414573 A JP5414573 A JP 5414573A JP S505523 A JPS505523 A JP S505523A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48054145A
Other languages
Japanese (ja)
Other versions
JPS5637967B2 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP5414573A priority Critical patent/JPS5637967B2/ja
Priority to DE2423811A priority patent/DE2423811A1/en
Priority to ES426414A priority patent/ES426414A1/en
Priority to FR7417294A priority patent/FR2229416A1/en
Publication of JPS505523A publication Critical patent/JPS505523A/ja
Publication of JPS5637967B2 publication Critical patent/JPS5637967B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP5414573A 1973-05-17 1973-05-17 Expired JPS5637967B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP5414573A JPS5637967B2 (en) 1973-05-17 1973-05-17
DE2423811A DE2423811A1 (en) 1973-05-17 1974-05-16 PROCESS FOR THE PRODUCTION OF FREEZE-DRIED 2,2'-ANHYDRO-1-BETA-D-ARABINOFURANOSYLCYTOSINE PREPARATIONS AND INJECTION PREPARATIONS
ES426414A ES426414A1 (en) 1973-05-17 1974-05-17 Method to produce a preparation of dry cyclycytden by freezing. (Machine-translation by Google Translate, not legally binding)
FR7417294A FR2229416A1 (en) 1973-05-17 1974-05-17 Cyclocytidine improved freeze-dried prepns. - by freeze-drying solns. of cyclocytidine and a saccharide, polyvinylpyrrolidone etc.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5414573A JPS5637967B2 (en) 1973-05-17 1973-05-17

Publications (2)

Publication Number Publication Date
JPS505523A true JPS505523A (en) 1975-01-21
JPS5637967B2 JPS5637967B2 (en) 1981-09-03

Family

ID=12962379

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5414573A Expired JPS5637967B2 (en) 1973-05-17 1973-05-17

Country Status (4)

Country Link
JP (1) JPS5637967B2 (en)
DE (1) DE2423811A1 (en)
ES (1) ES426414A1 (en)
FR (1) FR2229416A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139613A (en) * 1975-05-24 1976-12-02 Nippon Shinyaku Co Ltd An absorbable non-crystalline sterol glycoside monopalmitate ester and a method for preparing its pharmaceutical
WO1998034623A1 (en) * 1997-02-05 1998-08-13 Kirin Beer Kabushiki Kaisha Freeze-dried composition containing glycosphingolipid and process for producing the same
JP2001509512A (en) * 1997-07-11 2001-07-24 アストラ・フアーマシユウテイカルズ・リミテツド New formulation
US6417167B1 (en) 1997-02-05 2002-07-09 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing shingoglycolipid and process for preparing them

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658406C2 (en) * 1975-12-31 1984-04-26 Asahi Kasei Kogyo K.K., Osaka Process for the production of water-soluble pharmaceutical preparations containing N → 4 → -acylcytosine arabinoside
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
SE9604795D0 (en) * 1996-12-20 1996-12-20 Astra Pharma Prod New pharmaceutical formulation
KR0181252B1 (en) * 1996-12-31 1999-03-20 박원훈 Porous matrix sustained-release preparation by emulsion metho

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139613A (en) * 1975-05-24 1976-12-02 Nippon Shinyaku Co Ltd An absorbable non-crystalline sterol glycoside monopalmitate ester and a method for preparing its pharmaceutical
JPS5523246B2 (en) * 1975-05-24 1980-06-21
WO1998034623A1 (en) * 1997-02-05 1998-08-13 Kirin Beer Kabushiki Kaisha Freeze-dried composition containing glycosphingolipid and process for producing the same
US6417167B1 (en) 1997-02-05 2002-07-09 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing shingoglycolipid and process for preparing them
JP2001509512A (en) * 1997-07-11 2001-07-24 アストラ・フアーマシユウテイカルズ・リミテツド New formulation

Also Published As

Publication number Publication date
FR2229416A1 (en) 1974-12-13
DE2423811A1 (en) 1974-12-05
ES426414A1 (en) 1976-07-01
JPS5637967B2 (en) 1981-09-03

Similar Documents

Publication Publication Date Title
AU465372B2 (en)
AR201231Q (en)
AU465453B2 (en)
AU465434B2 (en)
AU471343B2 (en)
AU450229B2 (en)
JPS5637967B2 (en)
AR201229Q (en)
AU472848B2 (en)
AU466283B2 (en)
AU447540B2 (en)
AR200885A1 (en)
AU461342B2 (en)
AU471461B2 (en)
AR210729A1 (en)
AU1891376A (en)
CH559791A5 (en)
AU479714A (en)
CH565084A5 (en)
CH563281A5 (en)
CH562074A4 (en)
CH559845A5 (en)
AU479453A (en)
CH1675373A4 (en)
CH565830A5 (en)